GLP1 NAION warning: FDA orders class-wide labels for potential rare eye risk

Punkty podane przez więcej niż jedno medium

1. FDA requirement for NAION warnings on GLP-1 labels3 redakcje
2. NAION effects on vision2 redakcje
3. Drugs covered by the FDA labeling requirement2 redakcje
4. Evidence included in the FDA evaluation2 redakcje